The following criteria may be useful in selecting appropriate candidates for IDPN/IPN therapy:
- Patient has a trending albumin of 3.5 gm/dL or less.
- Patient has a disease or impairment that may affect the absorption of nutrients or require additional nutrients to maintain weight and strength.
| |
- Short bowel syndrome
- Inflammatory bowel disease
• Crohn’s disease
• Ulcerative colitis
• Bowel fistula
- Ostomies
- HIV/AIDS
- Diabetic gastroparesis
|
- Cancer/chemotherapy
- Chronic nausea/vomiting/diarrhea
- Wounds that are healing poorly
- Chronic inflammation/infections
- Dysphagia/severe mechanical alterations in diet
- Chronic anorexia
- Early satiety
|
| |
- Patient demonstrates protein/energy wasting.
- Patient demonstrates a progressive decline in weight or is significantly below standard body weight (SBW), if applicable.
- Subjective global assessment (SGA) yields a rating of 4 or below on a scale to 7.
- Patient demonstrates an inability to administer or tolerate oral supplements and/or tube feedings.
Records should indicate the patient cannot be maintained on oral/enteral feedings and that the patient’s clinical condition warrants more aggressive nutritional therapy. The clinical/laboratory documentation used for IDPN/IPN are:
- Albumin levels and other routine blood chemistries
- Current body weight, weight history, and weight loss, if applicable
- Current medications
- Allergies, if any
- Indications of oral intake and problems such as diarrhea, vomiting, and nausea
- RD monthly/quarterly progress notes and/or annual assessment
- Documentation of co-morbidities that would increase the nutritional needs and/or interfere with nutrition
Please note: No single parameter should verify a patient’s eligibility for IDPN/IPN therapy. Please consult your NutrePletion Resources dietitian at 1 800 626-4427 if you have any questions about an appropriate patient. |
